Montag A & Associates Inc. Buys 5,941 Shares of Danaher Corporation $DHR

Key Points

• Montag A & Associates increased its stake in Danaher by 30.1%, buying 5,941 shares to hold 25,653 shares worth about $5.88 million after the quarter.
• Danaher reported EPS of $2.06 (beating consensus) and revenue of $5.95B (slightly below expectations), and Wall Street's consensus is a “Moderate Buy” with a $240.70 target price.
• The company raised its quarterly dividend to $0.40 (annualized $1.60), giving a yield of ~0.9% and a payout ratio near 31%.

Montag A & Associates Inc. grew its stake in shares of Danaher Corporation (NYSE:DHR - Free Report) by 30.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 25,653 shares of the conglomerate's stock after acquiring an additional 5,941 shares during the quarter. Montag A & Associates Inc.'s holdings in Danaher were worth $5,881,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of DHR. Sivia Capital Partners LLC lifted its position in shares of Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock valued at $397,000 after acquiring an additional 119 shares during the period. First Trust Advisors LP lifted its position in shares of Danaher by 34.5% during the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock worth $10,947,000 after buying an additional 14,217 shares during the last quarter. Main Street Financial Solutions LLC lifted its position in shares of Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock worth $610,000 after buying an additional 886 shares during the last quarter. Ieq Capital LLC lifted its position in shares of Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock worth $14,957,000 after buying an additional 29,592 shares during the last quarter. Finally, HUB Investment Partners LLC lifted its position in shares of Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock worth $273,000 after buying an additional 325 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the company's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company's stock, valued at $1,060,642.99. This represents a 20.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 10.80% of the stock is currently owned by insiders.

Danaher Price Performance

Shares of DHR opened at $175.30 on Friday. Danaher Corporation has a 12-month low of $174.60 and a 12-month high of $242.80. The business has a 50-day simple moving average of $193.34 and a two-hundred day simple moving average of $213.20. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The stock has a market cap of $124.07 billion, a PE ratio of 33.91, a PEG ratio of 2.34 and a beta of 0.81.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion during the quarter, compared to analysts' expectations of $6 billion. During the same quarter in the prior year, the firm earned $1.88 EPS. The business's revenue for the quarter was up 3.7% compared to the same quarter last year. Analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 24th. Shareholders of record on Friday, March 27th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Friday, March 27th. This is a boost from Danaher's previous quarterly dividend of $0.32. Danaher's payout ratio is currently 30.95%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on DHR shares. Jefferies Financial Group restated a "buy" rating and set a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. UBS Group dropped their price objective on Danaher from $270.00 to $250.00 and set a "buy" rating for the company in a research report on Wednesday, April 22nd. Weiss Ratings restated a "hold (c)" rating on shares of Danaher in a research report on Friday, March 27th. KeyCorp restated an "overweight" rating on shares of Danaher in a research report on Thursday, January 29th. Finally, TD Cowen dropped their price objective on Danaher from $245.00 to $240.00 and set a "buy" rating for the company in a research report on Wednesday, April 22nd. Eighteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $240.70.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.